Keywords: abbott, 1st-qtr, profit, drops, 5m, health, care
Abbott's 1st-qtr profit drops 19% to $697.5M
Article | 23 April 2007
US health care major Abbott Laboratories said that its first-quarter 2007 net income fell 19% on the like, year-ago period, to $697.5 million, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
